Feasibility of randomizing Danish citizens aged 65-79 years to high-dose quadrivalent influenza vaccine vs. standard-dose quadrivalent influenza vaccine in a pragmatic registry-based setting: rationale and design of the DANFLU-1 trial
<strong>Background<br></strong> High-dose influenza vaccines provide better protection against influenza infection than standard-dose in persons aged 65 years and above; however, in most countries, high-dose vaccines are not widely implemented. Assessing the relative effectiveness...
| 主要な著者: | , , , |
|---|---|
| フォーマット: | Journal article |
| 言語: | English |
| 出版事項: |
BioMed Central
2022
|